EEG-Based Alzheimer's Disease Recognition Using Robust-PCA and LSTM Recurrent Neural Network.
Alzheimer’s disease (AD)
deep neural network (DNN)
electroencephalography (EEG)
principal component analysis (PCA)
recurrent neural network (RNN)
robust PCA (RPCA)
Journal
Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366
Informations de publication
Date de publication:
12 May 2022
12 May 2022
Historique:
received:
14
03
2022
revised:
02
05
2022
accepted:
10
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
1
6
2022
Statut:
epublish
Résumé
The use of electroencephalography (EEG) has recently grown as a means to diagnose neurodegenerative pathologies such as Alzheimer's disease (AD). AD recognition can benefit from machine learning methods that, compared with traditional manual diagnosis methods, have higher reliability and improved recognition accuracy, being able to manage large amounts of data. Nevertheless, machine learning methods may exhibit lower accuracies when faced with incomplete, corrupted, or otherwise missing data, so it is important do develop robust pre-processing techniques do deal with incomplete data. The aim of this paper is to develop an automatic classification method that can still work well with EEG data affected by artifacts, as can arise during the collection with, e.g., a wireless system that can lose packets. We show that a recurrent neural network (RNN) can operate successfully even in the case of significantly corrupted data, when it is pre-filtered by the robust principal component analysis (RPCA) algorithm. RPCA was selected because of its stated ability to remove outliers from the signal. To demonstrate this idea, we first develop an RNN which operates on EEG data, properly processed through traditional PCA; then, we use corrupted data as input and process them with RPCA to filter outlier components, showing that even with data corruption causing up to 20% erasures, the RPCA was able to increase the detection accuracy by about 5% with respect to the baseline PCA.
Identifiants
pubmed: 35632105
pii: s22103696
doi: 10.3390/s22103696
pmc: PMC9145212
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Alzheimers Dis. 2014;2014:349249
pubmed: 24868482
Lancet. 2006 Apr 15;367(9518):1262-70
pubmed: 16631882
BMJ. 2008 Feb 2;336(7638):258-62
pubmed: 18187696
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
J Neurosci Methods. 2007 Apr 15;161(2):342-50
pubmed: 17156848
Neuroimage. 2020 Nov 15;222:117203
pubmed: 32763427
Clin Neurophysiol. 2001 Aug;112(8):1378-87
pubmed: 11459677
Neural Comput. 1997 Nov 15;9(8):1735-80
pubmed: 9377276
Front Neurosci. 2020 Jul 21;14:641
pubmed: 32848530
J Clin Neurophysiol. 2001 Nov;18(6):570-5
pubmed: 11779971
PLoS One. 2018 Mar 20;13(3):e0193607
pubmed: 29558517
Curr Alzheimer Res. 2010 Sep;7(6):487-505
pubmed: 20455865
Bioinformatics. 2004 Jul 22;20(11):1728-36
pubmed: 14988110
Clin Neurophysiol. 2004 Jul;115(7):1490-505
pubmed: 15203050
Electroencephalogr Clin Neurophysiol. 1998 Mar;106(3):229-37
pubmed: 9743281
Comput Biol Med. 2022 Jan 25;143:105242
pubmed: 35093844
Curr Alzheimer Res. 2009 Aug;6(4):324-30
pubmed: 19689230
Sci Rep. 2018 Jun 15;8(1):9161
pubmed: 29907747
Electroencephalogr Clin Neurophysiol. 1994 Mar;90(3):242-5
pubmed: 7511505
Electroencephalogr Clin Neurophysiol. 1983 Apr;55(4):372-80
pubmed: 6187529